Form 4 for FDMT 4D Molecular Therapeutics, Inc.
Accepted 2026-06-25 16:38:46 ET · period of report 2026-06-23 · accession 0001920738-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-25 16:38 | 2026-06-23 | FDMT | Bizily Scott | CLO | M - OptEx | $4.14 | +9,810 | 18.4K | +114% | +$40.6K |
| DT | 2026-06-25 16:38 | 2026-06-23 | FDMT | Bizily Scott | CLO | S - Sale+OE | $12.00 | -9,810 | 8,617 | -53% | -$117.7K |
| DT | 2026-06-25 16:38 | 2026-06-23 | FDMT | Bizily Scott | CLO | M - OptEx | $0.00 | -9,810 | 63.8K | -13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-23 | M | A | 9,810 | $4.14 | 18,427 | D | — | — | (F1) Reflects 5,023 shares of the Issuer's common stock purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3. |
| 2 | Common | Common Stock | 2026-06-23 | S | D | 9,810 | $12.00 | 8,617 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-06-23 | M | D | 9,810 | $0.00 | 63,785 | D | $4.14 · — to 2035-03-05 | 9,810 Common Stock | (F2) The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of March 6, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company. |